Su et al J. Cell Biol. vol. 112 (3) pp.377-384, Feb. 1991. |
Albrecht, et al., 1992. "Herpesvirus Saimiri Has a Gene Specifying a Homologue of the Cellular Membrane Glycoprotein CD59" Virology 190:527-530. |
Brown, et al., 1992. "Sorting of GPI-Anchored Proteins to Glycolipid- Enriched Membrane Subdomains during Transport to the Apical Cell Surface" Cell. 68:533-544. |
Butikofer, et al., 1989. "Enrichment of Two Glycosyl-Phosphatidylinositol-Anchored Proteins, Acetylcholinesterase and Decay Accelerating Factor, in Vesicles Released form Human Red Blood Cells" Blood. 74:1481-1485. |
Cinek, et al., 1992. "The nature of large noncovalent complexes containing glycosylphosphatidylinositol-anchored membrane glycoproteins and protein tyrosine kinases" J. Immunol. 149:2262-2270. |
Davies, et al., 1989. "CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells" J. Exp. Med. 170:637-654. |
Ferguson, et al., 1988. "Cell-Surface Anchoring of Proteins via Glycosyl-Phosphatidylinositol Structure" Ann. Rev. Biochem., 57:285-320. |
Holguin, et al., 1989. "Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria" J. Clin. Invest. 84:7-17. |
Lublin, et al., 1991. "Phospholipid-anchored and Transmembrane Versions of Either Decay-Accelerating Factor or Membrane Cofactor Protein Show Equal Efficiency in Protection from Complement-mediated Cell Damage" J. Exp. Med., 174:35-44. |
McMahon, et al., 1989. "Ectopic Expression of the Proto-Oncogene int-1 in Xenopus Embryos Leads to Duplication of he Embryonic Axis" Cell. 58:1075-1084. |
Meri, et al., 1990. "Human protection (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers" Immunology 71:1-9. |
Moran, et al., 1992. "Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo" J. Immunol. 140:1736-1743. |
Nakano, et al., 1993. "Expressions and Characterizations of Recompinant MACIFs (CD59) of Three Different Lengths" Molec. Immunol. 30(suppl. 1):37. |
Norris, et al., 1993. "Structure-Function Relationships of CD59" Blood, 82(suppl.):202a. |
Okada, et al., 1989. "Monoclonal Antibodies Capable of Causing Hemolysis Of Neuraminidase-Treated Human Erythrocytes by Homologus Complement" J. Immunol. 143:2262-2266. |
Okada, et al., 1989. "20 KDa Homologous Restriction Factor of Complement Resembles T Cell Activating Protein" Biochem. Biophys. Res. Commun. 162: 1553-1559. |
Petranka, et al., 1993. "The Structure and Function fo CD59 : The Importance of the Disulfide Structure and Identification of a Primary Epitope" Molec. Immunol. 30(suppl. 1):44. |
Philbrick, et al., 1990. "The CD59 Antigen Is A Structural Homologue of Murine Ly-6 Antigens but Lacks Interferon Inducibility" Eur. J. Immunol. 20:87-92. |
Purcell, et al., 1991. "Alternatively Spliced RNAs Encode Several Isoforms of CD46 (MCP), A Regulator of Complement Activation" Immunogenetics 33:335-344. |
Rollins, et al., 1990. "The Complement-Inhibitory Activity of Cd59 Resides in its Capacity to Block Incorporation of C9 into Membrane C5b-9" J. Immunol. 144:3478-3483. |
Rollins, et al., 1991. "Inhibition of Homologous Complement by CD59 is Mediated by A Species-Selective Recognition Conferred Through Binding to C8 within C5b-8 or C9 within C5b-9" J. Immunol. 146:2345-2351. |
Rother, et al., 1994. "Inhibition of Complememt-Mediated Cytolysis by the terminal Complement Inhibitor of Herpesvirus Saimiri" J. Virol. 68:730-737. |
Sawada, et al., 1990. "Isolation and Expression of the Full-Length cDNA Encoding CD59 Antigen of Human Lymphocytes" DNA and Cell. Biol. 9:213-220. |
Seaman, et al., 1991. "Molecular Cloning of gp42, a Cell-Surface Molecle That Is Selectively Induced on Rat Natural Killer Cells by Interleukin 2: Glycolipid Membrane Anchoring and Capacity for Transmembrane Signaling" J. Exp. Med. 173:251-260. |
Stefanova, et al., 1989. "Characterization of a Broadly Expressed Human Leucocyte Surface Antigen MEM-43 Anchored in Membrane Through Phosphatidylinositol" Mol. Immunol. 26:153-161. |
Su, et al., 1991. "The Glycolsyl Phosphatidylinositol Anchor Is Critical for Ly-6A/E-Mediated T Cell Activation" J. Cell Biol. 112:377-384. |
Suter, et al., 1992. "NGF/BDNF Chimeric Proteins: Analysis of Neurotrophin Specificity by Homolog-scanning Mutagenesis" J. Neurosci. 12:306-318. |
Tone, et al., 1992. "Gene Structure of Human CD59 and Demonstration that Discrete mRNAs Are Generated by Alternative Polyadenylation" J. Mol. Biol. 227:971-976. |
Venneker, et al., 1992. "CD59: A Molecule Involved in Antigen Presentation as well as Downregulation of Membrane Attack Complex" Exp. Clin. Immunogenet. 9:33-47. |
Walsh, et al., 1991. "Transfection of Human CD59 Complementary DNA into Rat Cells Confers Resistance to Human Complement" Eur. J. Immunol. 21:847-850. |
Whitlow, et al., 1991. "H19, a Surface Membrane Molecule Involved in T-Cell Activation, Inhibits Channel Formation by Human Complement" Cell Immunol. 126:176-184. |
Whitlow, et al., 1993. "Cells Lacking Glycan Phosphatidylinositol-Linked Proteins Have Impaired Ability to Vesiculate" Blood. 81:510-516. |
Wing, et al., 1992. "Oligodendrocytes Lack Glycolipid Anchored Proteins which Protect them against Complement Lysis by Incorporation of CD59" Immunology. 76:140-145. |
Zalman, et al., 1986. "Isolation of a Human Erythrocyte Memebrane Protein Capable of Inhibiting Expression of Homologous Complemennt Transmembrane Channels" Proc. Natl. Acad. Sci. USA. 83:6975-6979. |
Zhao, et al., 1991. "Amplified Gene Expression in CD59-Transfected Chinese Hamster Ovary Cells Confers Protection against the Membrane Attack Complex of Human Complement" J. Biol. Chem. 266:13418-13422. |
Lehto, et al., 1993. "Interactions of Soluble CD59 with the Terminal Complement Complexes: CD59 and C9 Compete for A Nascent Epitope on C8" J. Immunol. 151:4941-4949. |
Okada et al., 1990. "Erythrocytes of Patients with Paroxysmal Nocturnal Haemoglobinuria Acquire Resistance to Complement Attack by a Purified 20-kD Homologous Restriction Factor" Clin. Exp. Immunol. 80:109-113. |
Rooney et al., 1992. "Characterization of the Membrane Attack Complex Inhibitory Protein CD59 Antigen on Human Amniotic Cells and in Amniotic Fluid" Immunol. 76:541-547. |
Waneck et al., 1988. "Conversion of a PI-Anchored Protein to an Integral Membrane Protein by a Single Amino Acid Mutation" Science. 24:697-699. |
Rotoli et al., 1989, "Paroxysmal Nocturnal Hemoglobinuria" Seminars in Hematology, vol. 26, pp. 201-207. |